InnoTherapy Inc (246960) — Cash Flow-to-Debt Ratio
InnoTherapy Inc (246960) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of ₩-107.41 Million could theoretically repay 0% of its total liabilities (₩50.78 Billion) in one year. See InnoTherapy Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
InnoTherapy Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for InnoTherapy Inc across 10 annual periods. Also explore net asset momentum of InnoTherapy Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for InnoTherapy Inc (2015–2024)
Year-by-year debt coverage analysis for InnoTherapy Inc. For market capitalisation and broader financial context, see 246960 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.70x | ₩-5.96 Billion | ₩8.54 Billion | ▼ -178.5% |
| 2023 | -0.25x | ₩-2.82 Billion | ₩11.26 Billion | ▼ -8.4% |
| 2022 | -0.23x | ₩-4.10 Billion | ₩17.77 Billion | ▼ -26.4% |
| 2021 | -0.18x | ₩-3.98 Billion | ₩21.80 Billion | ▲ +72.0% |
| 2020 | -0.65x | ₩-2.87 Billion | ₩4.41 Billion | ▲ +57.1% |
| 2019 | -1.52x | ₩-3.26 Billion | ₩2.15 Billion | ▼ -15.5% |
| 2018 | -1.31x | ₩-2.18 Billion | ₩1.66 Billion | ▲ +35.6% |
| 2017 | -2.04x | ₩-2.26 Billion | ₩1.11 Billion | ▼ -74.1% |
| 2016 | -1.17x | ₩-1.12 Billion | ₩957.90 Million | ▼ -1360.6% |
| 2015 | -0.08x | ₩-1.15 Billion | ₩14.34 Billion | — |